Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Minerva Neurosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 19 | 17 | −2 |
| Shares | 1.73M | 1.68M | −48.7K (−2.8%) |
| Value | $2.75M | $2.69M | −$61.2K (−2.2%) |
New holders (2)
Institutions that held Minerva Neurosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 822 | $1.00K | 0.00% |
| Royal Bank of Canada | 176 | $0 | 0.00% |
Sold out (4)
Institutions that held Minerva Neurosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 28,881 | $46.0K |
| Bridgeway Capital Management, LLC | 15,436 | $24.5K |
| Group One Trading, L.P. | 5,785 | $9.20K |
| Bank of America Corp | 6 | $10 |